HLB Co., Ltd.
028300
Rankning i aktier
#4107
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Aktiekurs
$29.70
Marknadsvärde
$3.95B
Förändring (1 dag)
0.47%
Förändring (1 år)
2.42%
Land
KR
Handel HLB Co., Ltd. (028300)
Kategori
Healthcare
EPS för HLB Co., Ltd. (028300)
EPS per June 2026 TTM: $-1.12
Enligt HLB Co., Ltd.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-1.12. Vid slutet av 2023 hade bolaget ett EPS på $-1.20, en ökning jämfört med EPS från 2022 som var $-0.55.
EPS-historik för HLB Co., Ltd. från 2012 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $-1.12 | 132.67% |
| 2024 | $-0.48 | -60.27% |
| 2023 | $-1.20 | 119.01% |
| 2022 | $-0.55 | -19.90% |
| 2021 | $-0.69 | 15.14% |
| 2020 | $-0.60 | 57.18% |
| 2019 | $-0.38 | -259.25% |
| 2018 | $0.24 | -240.42% |
| 2017 | $-0.17 | 40.25% |
| 2016 | $-0.12 | -194.53% |
| 2015 | $0.13 | -689.86% |
| 2014 | $-0.02 | -80.40% |
| 2013 | $-0.11 | 8.00% |
| 2012 | $-0.10 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| $17.32 | -1,650.86% |
US
|
|
| $-7.98 | 614.54% |
US
|
|
| $-5.29 | 373.67% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,583.88% |
NL
|
